| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $951K | — |
| R&D Expense | $12.4M | +104.5% |
| SG&A Expense | $383K | +56.3% |
| Operating Income | -$18.1M | -101.1% |
| Interest Expense | $6K | -99.0% |
| Net Income | -$18.1M | -80.3% |
| EPS (Basic) | -$1.20 | -39.5% |
| EPS (Diluted) | -$1.20 | -39.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $455K | -97.3% |
| Inventory | $2.2M | +19.5% |
| Current Assets | $2.6M | -85.6% |
| Total Assets | $2.8M | -85.0% |
| Current Liabilities | $3.3M | +56.0% |
| Total Liabilities | $3.3M | +45.3% |
| Stockholders' Equity | -$466K | -102.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.7M | -171.4% |
| Capital Expenditures | $2K | -93.1% |
| Investing Cash Flow | -$2K | +93.1% |
| Financing Cash Flow | -$471K | -102.1% |
| Free Cash Flow | -$15.7M | -170.1% |